Introduction:
Rarity Bioscience provides ultrasensitive mutation detecting in bone marrow, blood and other liquid biopsies for research, pharma, CROs and Hospital labs/clinics, analyzing both genomic DNA (gDNA) and circulating tumour DNA (ctDNA) using its propriatary superRCA assay.
https://raritybioscience.com/applications/

Sensitivity:
The sensitivity of the superRCA assay enables detection of down to 1 mutation among 100.000 wild types, or the equivalent of MAFs/VAFs down to 0.001%.
https://raritybioscience.com/technology/

Standard gene/gene-panel assays can be found here:
https://raritybioscience.com/assays/

A large library of private mutations available upon inquiry:
https://raritybioscience.com/contact/

Newly available assays are advertized on linkedIn:
https://www.linkedin.com/company/rarity-bioscience/

Sample analysis service:
Using the superRCA technology our sample analysis team rapidly detects rare DNA mutations in various tissues such as bone marrow, but also including gDNA and ctDNA from blood and other liquid biopsies. Our services include analysis using pre-defined or custom tumor panels or gene specific assays.
https://raritybioscience.com/assays/#services

Our Services team can assist with:
- DNA extraction
- Novel assay design & verification
- Assay validations according to CLSI guidelines
- Sample analysis
- superRCA technology transfer

Contact us for further discussions or quotes by using the link below, or by using the scientist.com platform.
https://raritybioscience.com/assays/#services